INNOSCIENCE (02577) Surges Over 13% to New High as First Half Achieves Positive Gross Margin, AI and Data Center Sales Jump 180%

Stock News
Sep 01

INNOSCIENCE (02577) surged over 13%, reaching a new high of HK$98.7. As of press time, the stock was up 12.36% to HK$97, with trading volume of HK$1.027 billion.

The company previously released its interim results. In the first half, INNOSCIENCE achieved sales revenue of 553 million yuan, up 43.4% year-over-year. The gross margin reached 6.8%, turning positive for the first time compared to the same period in 2024, representing a significant improvement of 28.4 percentage points. This marks the company's first positive gross margin achievement. Net loss was approximately 429 million yuan, narrowing by 12.16% year-over-year.

Notably, in the first half, the company's sales targeting AI and data centers grew 180% year-over-year, with 100V gallium nitride-based 48V-12V applications entering mass production.

Additionally, INNOSCIENCE has partnered with leading robotics companies and successfully launched the world's first gallium nitride robot. "This year, the shipment volume of gallium nitride robots powered by our chips is expected to exceed 10,000 units. Each robot requires approximately 300 gallium nitride chips. As technology continues to iterate, humanoid robots' demand for gallium nitride chips will rise significantly, with chip usage per robot potentially increasing to 1,000 units to enable more complex and challenging movements in key areas such as fingers and waist," the company stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10